Total Payments
$35,878
2024 Payments
$27,064
Companies
20
Transactions
45
Medicare Patients
398
Medicare Billing
$27,969
Payment Breakdown by Category
Research$25,000 (69.7%)
Other$6,015 (16.8%)
Consulting$2,843 (7.9%)
Food & Beverage$1,583 (4.4%)
Gifts$370.00 (1.0%)
Education$67.07 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $25,000 | 1 | 69.7% |
| Honoraria | $6,015 | 6 | 16.8% |
| Consulting Fee | $2,843 | 2 | 7.9% |
| Food and Beverage | $1,583 | 27 | 4.4% |
| Gift | $370.00 | 1 | 1.0% |
| Education | $67.07 | 8 | 0.2% |
Payments by Type
Research
$25,000
1 transactions
General
$10,878
44 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| RECORDATI_RARE_DISEASES_INC. | $26,754 | 6 | $0 (2024) |
| NATUS MEDICAL INCORPORATED | $4,566 | 5 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,838 | 2 | $0 (2022) |
| iScreen Vision Inc. | $1,000 | 2 | $0 (2018) |
| Kaneka Pharma America LLC | $370.00 | 1 | $0 (2018) |
| Dompe US, Inc. | $277.99 | 4 | $0 (2024) |
| Amgen Inc. | $139.42 | 1 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $128.14 | 1 | $0 (2023) |
| Spark Therapeutics, Inc. | $125.00 | 1 | $0 (2021) |
| Santen Inc. | $110.26 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,064 | 12 | RECORDATI_RARE_DISEASES_INC. ($26,545) |
| 2023 | $539.30 | 8 | RECORDATI_RARE_DISEASES_INC. ($208.80) |
| 2022 | $1,026 | 3 | NATUS MEDICAL INCORPORATED ($1,000) |
| 2021 | $5,606 | 7 | NATUS MEDICAL INCORPORATED ($3,500) |
| 2019 | $28.59 | 6 | Retrophin, Inc. ($28.59) |
| 2018 | $907.03 | 4 | iScreen Vision Inc. ($500.00) |
| 2017 | $706.69 | 5 | iScreen Vision Inc. ($500.00) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/16/2024 | RECORDATI_RARE_DISEASES_INC. | CYSTADROPS (Drug) | — | Cash or cash equivalent | $25,000.00 | Research |
| Study: Donald Suh at The Regents of the University of California on Assessment and Improvement of Treatment for Corneal Involvement in Cystinosis • Category: OCULAR METABOLIC AGENT | ||||||
| 10/01/2024 | RECORDATI_RARE_DISEASES_INC. | CYSTADROPS (Drug) | Honoraria | Cash or cash equivalent | $515.00 | General |
| Category: OCULAR METABOLIC AGENT | ||||||
| 09/04/2024 | Leadiant Biosciences, Inc. | CYSTARAN (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: CYSTINOSIS | ||||||
| 07/18/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $100.71 | General |
| Category: SOLUTION/ DROPS | ||||||
| 07/15/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: SOLUTION/ DROPS | ||||||
| 06/29/2024 | RECORDATI_RARE_DISEASES_INC. | CYSTADROPS (Drug) | Consulting Fee | Cash or cash equivalent | $1,030.00 | General |
| Category: OCULAR METABOLIC AGENT | ||||||
| 06/09/2024 | Glaukos Corporation | iStent Trabecular Micro-Bypass System Model iS3 (Device) | Food and Beverage | Cash or cash equivalent | $25.46 | General |
| Category: Glaucoma | ||||||
| 05/29/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $125.30 | General |
| Category: SOLUTION/ DROPS | ||||||
| 05/29/2024 | Glaukos Corporation | iAccess Precision Blade (Device) | Food and Beverage | Cash or cash equivalent | $23.51 | General |
| Category: Glaucoma | ||||||
| 05/08/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $139.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/08/2024 | Leadiant Biosciences, Inc. | CYSTARAN (Drug) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: CYSTINOSIS | ||||||
| 11/30/2023 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Food and Beverage | In-kind items and services | $128.14 | General |
| Category: Oncology | ||||||
| 11/11/2023 | RECORDATI_RARE_DISEASES_INC. | CARBAGLU (Drug), CYSTADANE | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: METABOLIC AGENT | ||||||
| 11/07/2023 | RECORDATI_RARE_DISEASES_INC. | CARBAGLU (Drug), CYSTADANE | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: METABOLIC AGENT | ||||||
| 10/27/2023 | RECORDATI_RARE_DISEASES_INC. | CYSTADROPS (Drug) | Food and Beverage | In-kind items and services | $67.89 | General |
| Category: OCULAR METABOLIC AGENT | ||||||
| 10/04/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $45.16 | General |
| Category: TEPEZZA | ||||||
| 03/30/2023 | Santen Inc. | Verkazia (Drug) | Food and Beverage | In-kind items and services | $110.26 | General |
| Category: Cyclosporine | ||||||
| 03/25/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: TEPEZZA | ||||||
| 03/08/2023 | Leadiant Biosciences, Inc. | CYSTARAN (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: CYSTINOSIS | ||||||
| 12/02/2022 | NATUS MEDICAL INCORPORATED | — | Honoraria | Cash or cash equivalent | $1,000.00 | General |
| 08/03/2022 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 03/25/2022 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $25.36 | General |
| 12/09/2021 | Spark Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/05/2021 | Alcon Vision LLC | AcrySof (Device) | Food and Beverage | In-kind items and services | $32.97 | General |
| Category: Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Donald Suh at The Regents of the University of California on Assessment and Improvement of Treatment for Corneal Involvement in Cystinosis | RECORDATI_RARE_DISEASES_INC. | $25,000 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 259 | 323 | $99,081 | $16,814 |
| 2022 | 5 | 108 | 132 | $47,776 | $8,815 |
| 2021 | 2 | 31 | 34 | $11,546 | $2,340 |
Total Patients
398
Total Services
489
Medicare Billing
$27,969
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 78 | $33,540 | $5,899 | 17.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $23,719 | $3,708 | 15.6% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 74 | 113 | $19,323 | $3,494 | 18.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 64 | $18,624 | $3,154 | 16.9% |
| 92134 | Imaging of retina | Office | 2023 | 18 | 18 | $2,250 | $360.23 | 16.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 12 | 13 | $1,625 | $200.42 | 12.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 53 | $15,423 | $2,884 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 32 | $13,917 | $2,597 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $11,740 | $2,140 | 18.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $3,960 | $686.74 | 17.3% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2022 | 15 | 16 | $2,736 | $506.09 | 18.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 21 | $6,043 | $1,222 | 20.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 13 | $5,503 | $1,118 | 20.3% |
About Dr. Donny Suh, MD
Dr. Donny Suh, MD is a Ophthalmology healthcare provider based in Irvine, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1295727022.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donny Suh, MD has received a total of $35,878 in payments from pharmaceutical and medical device companies, with $27,064 received in 2024. These payments were reported across 45 transactions from 20 companies. The most common payment nature is "" ($25,000).
As a Medicare-enrolled provider, Suh has provided services to 398 Medicare beneficiaries, totaling 489 services with total Medicare billing of $27,969. Data is available for 3 years (2021–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Pediatric Ophthalmology and Strabismus Specialist
- Location Irvine, CA
- Active Since 08/18/2005
- Last Updated 01/23/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1295727022
Products in Payments
- CYSTADROPS (Drug) $26,613
- Lacriflow (Medical Supply) $370.00
- OXERVATE (Drug) $277.99
- CARBAGLU (Drug) $140.91
- TEPEZZA (Biological) $139.42
- KOSELUGO (Drug) $128.14
- Verkazia (Drug) $110.26
- CYSTARAN (Drug) $77.17
- TEPEZZA (Drug) $67.17
- CUVITRU (Biological) $66.79
- Luxor (Device) $56.22
- XIIDRA (Drug) $37.65
- AcrySof (Device) $32.97
- iStent inject W (Device) $30.10
- (820) Cholbam (Drug) $28.59
- iStent Trabecular Micro-Bypass System Model iS3 (Device) $25.46
- iAccess Precision Blade (Device) $23.51
- Prokera (Device) $16.71
- Cholbam (Drug) $0.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Irvine
Baruch Kuppermann, Md, MD
Ophthalmology — Payments: $996,400
Ophthalmology $996,400
Dr. Marjan Farid, Md, MD
Ophthalmology — Payments: $673,334
Ophthalmology $673,334
Dr. Rhett Schiffman, Md, MD
Ophthalmology — Payments: $461,992
Ophthalmology $461,992
Dr. Mitul Mehta, Md, MD
Ophthalmology — Payments: $221,612
Ophthalmology $221,612
Dr. Andrew Browne, M.d., Ph.d, M.D., PH.D
Ophthalmology — Payments: $86,139
Ophthalmology $86,139
Dr. Sameh Mosaed, Md, MD
Ophthalmology — Payments: $85,352
Ophthalmology $85,352